Huron Pharmaceuticals

Huron Pharmaceuticals was a privately held U.S. pharmaceutical ingredient supplier and active pharmaceutical ingredient (API) repackager/distributor based in Farmington Hills, Michigan. The company appears to have focused on sourcing, testing, repackaging, and supplying pharmaceutical ingredients to compounding pharmacies and related customers rather than developing a proprietary therapeutic pipeline. Publicly available descriptions state that it was independently owned and operated by pharmacists and emphasized ingredient quality testing through an independent FDA-registered laboratory. FDA records show the company operated a drug manufacturing facility and received a 2017 warning letter related to CGMP deficiencies for API handling and distribution. Business registry sources indicate the Michigan entity has since been dissolved, so it does not appear to be an active operating company.